Trial Profile
Comparison of Dabigatran and Enoxaparin in prophylaxy of Thromboembolic events in patient with total knee replacement surgery in Shariati hospital in 1392.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- 28 May 2014 New trial record